Arbutus Biopharma Corp. (ABUS)
4.53
-0.17
(-3.62%)
USD |
NASDAQ |
Mar 06, 16:00
4.49
-0.04
(-0.88%)
After-Hours: 20:00
Arbutus Biopharma Cash from Investing (Quarterly) : -10.23M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Moderna, Inc. | -48.00M |
| Merck & Co., Inc. | -11.20B |
| Pfizer Inc. | -6.146B |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Alnylam Pharmaceuticals, Inc. | -37.17M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.840M |
| Cash from Financing (Quarterly) | 0.8496M |
| Free Cash Flow | -44.78M |
| Free Cash Flow Per Share (Quarterly) | -0.0305 |
| Free Cash Flow to Equity (Quarterly) | -5.447M |
| Free Cash Flow to Firm (Quarterly) | -5.817M |
| Free Cash Flow Yield | -5.17% |